MedPath

Parecoxib

Generic Name
Parecoxib
Brand Names
Dynastat
Drug Type
Small Molecule
Chemical Formula
C19H18N2O4S
CAS Number
198470-84-7
Unique Ingredient Identifier
9TUW81Y3CE
Background

Parecoxib is a water-soluble and injectable prodrug of valdecoxib. It is marketed as Dynastat in the European Union. Parecoxib is a COX2 selective inhibitor in the same category as celecoxib (Celebrex) and rofecoxib (Vioxx). As it is injectable, it can be used perioperatively when patients are unable to take oral medications. It is approved through much of Europe for short term perioperative pain control much in the same way ketorolac (Toradol) is used in the United States. A letter of non-approval for parecoxib was issued by the FDA in 2005.

Indication

Used for short term perioperative pain control.

Associated Conditions
Postoperative pain

Effect of Parecoxib on Postoperative Shoulder Pain After Gynecological Laparoscopy.

Not Applicable
Completed
Conditions
Anti-Inflammatory Agents, Non-Steroidal
Pain, Postoperative
Laparoscopy
Interventions
First Posted Date
2011-07-13
Last Posted Date
2011-11-22
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Target Recruit Count
126
Registration Number
NCT01393925
Locations
🇨🇳

Department of Anesthesiology,,The first affiliated hospital of Sun Yat-Sen university, Guangzhou, Guangdong, China

COX-2 Inhibitor Versus Glucocorticoid Versus Both Combined

Phase 4
Completed
Conditions
Rupture of Anterior Cruciate Ligament
Interventions
First Posted Date
2011-05-27
Last Posted Date
2011-05-27
Lead Sponsor
Asker & Baerum Hospital
Target Recruit Count
93
Registration Number
NCT01361789
Locations
🇳🇴

Baerum Hospital, Rud, Norway

Can Parecoxib Reduce Post-operative Ipsilateral Shoulder Pain?

Phase 2
Completed
Conditions
Post-operative Pain
Shoulder Pain
Interventions
Other: Control
First Posted Date
2011-02-03
Last Posted Date
2016-12-06
Lead Sponsor
Chiang Mai University
Target Recruit Count
160
Registration Number
NCT01288924
Locations
🇹🇭

Department of Anesthesiology, Faculty of Medicine, Maung, Chiang Mai, Thailand

🇹🇭

Department of Anesthesiology, Faculty of Medicine, Chiang Mai University, Maung, Chiang Mai, Thailand

Effect Study of Parecoxib to Treat Emergence Delirium and Postoperative Pain

Phase 4
Conditions
Emergence Delirium
Postoperative Pain
Interventions
First Posted Date
2010-10-14
Last Posted Date
2011-03-25
Lead Sponsor
First Affiliated Hospital, Sun Yat-Sen University
Target Recruit Count
900
Registration Number
NCT01221025
Locations
🇨🇳

The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

The Correlation of COX-2 Expression in Human Polymorphonuclear Leukocytes/Macrophages (PMNL/MP) and Postoperative Pain

Phase 4
Completed
Conditions
Post-Operative Pain
Interventions
First Posted Date
2010-08-23
Last Posted Date
2015-04-17
Lead Sponsor
Xianwei Zhang
Target Recruit Count
90
Registration Number
NCT01186159
Locations
🇨🇳

Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China

Modulation of Remifentanil-induced Postinfusion Hyperalgesia

Phase 4
Completed
Conditions
Hyperalgesia, Secondary
Interventions
First Posted Date
2008-11-05
Last Posted Date
2011-07-01
Lead Sponsor
Ullevaal University Hospital
Target Recruit Count
16
Registration Number
NCT00785863
Locations
🇳🇴

Ullevaal University Hospital, Oslo, Norway

A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery

Phase 3
Completed
Conditions
Pain
Interventions
Drug: Placebo/Valdecoxib
Other: Placebo/Placebo
First Posted Date
2008-03-14
Last Posted Date
2008-10-10
Lead Sponsor
Pfizer
Target Recruit Count
1671
Registration Number
NCT00636064
Locations
🇬🇧

Pfizer Investigational Site, Oxford, United Kingdom

Efficacy And Safety Of Parecoxib 40mg vs. Ketoprofen 100mg In The Management Of Acute Renal Colic

Phase 4
Completed
Conditions
Pain
Interventions
First Posted Date
2007-11-04
Last Posted Date
2013-01-28
Lead Sponsor
Pfizer
Target Recruit Count
340
Registration Number
NCT00553605
Locations
🇵🇪

Pfizer Investigational Site, Lima, Peru

Effect of Parecoxib on Post-craniotomy Pain

Phase 4
Completed
Conditions
Anaesthesia
Interventions
First Posted Date
2007-04-03
Last Posted Date
2013-05-30
Lead Sponsor
Melbourne Health
Target Recruit Count
130
Registration Number
NCT00455117
Locations
🇦🇺

Royal Melbourne Hospital, Melbourne, Victoria, Australia

Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation

Phase 4
Withdrawn
Conditions
Pain, Postoperative
First Posted Date
2007-02-15
Last Posted Date
2012-03-14
Lead Sponsor
Pfizer
Registration Number
NCT00435747
© Copyright 2025. All Rights Reserved by MedPath